How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)
@article{TLCR41998, author = {Bing Xia and Misako Nagasaka and Viola W. Zhu and Sai-Hong Ignatius Ou and Ross A. Soo}, title = {How to select the best upfront therapy for metastatic disease? Focus on ALK-rearranged non-small cell lung cancer (NSCLC)}, journal = {Translational Lung Cancer Research}, volume = {9}, number = {6}, year = {2020}, keywords = {}, abstract = {}, issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/41998} }